NEXT-GEN BIOACTIVES

Clinical studies show MELAVOID® reduces tyrosinase enzyme levels by 63% compared to the control, helping to decrease melanin production.

Clinical results show Acxosome®-CICA increases Hyaluronan Synthase 3 (HAS3) expression by 4×, enhancing the skin’s hyaluronic acid production.

Clinical studies show Derma-Clera® enhances skin recovery, improving anti-irritation effects by up to 63.1%, outperforming conventional agents and supporting skin barrier repair.

Clinical studies shows Dendriclear® balances acneic and non-acneic strains, boosting the skin's natural defense.

Clinical studies shows that 98–100% of sensitive adults and babies showed no adverse reactions, confirming excellent skin compatibility.

Clinical studies shows that Oligopeptide-1 eliminates harmful free radicals like hydroxyl and peroxyl that cause oxidative stress.

46% Increase in Epidermal Thickness and Visible Wrinkle Reduction

 

Users reported enhanced skin protection and reduced sensitivity to UV exposure after using Raybloc®